-
Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
10 Oct 2025 12:24 GMT
… and uncertainties inherent in product research and development, including the uncertainty of … on request from Johnson & Johnson. Johnson & Johnson does not … pathophysiology of depression: potential for pharmacological intervention. CNS Drugs. 2013; …
-
Johnson & Johnson Launches "Dual Control" Campaign in Asia Pacific to Empower Patients
09 Oct 2025 02:50 GMT
New IBD research shows that, even during clinical remission, people living with Crohn's disease continue to experience greater work impairment than the general population
The new campaign aims to empower patients to take dual control of disease …
-
Jury orders Johnson & Johnson to pay $966 million over talc-linked cancer death
09 Oct 2025 00:41 GMT
It looks like Johnson & Johnson will have to part with nearly a billion dollars. A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial …
-
Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025
09 Oct 2025 20:15 GMT
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025 before the U.S. financial markets open. The company will host a …
-
Opinion: Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people
09 Oct 2025 16:40 GMT
In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last year its pro bono technical R&D support on …
-
Pharmaceutical Market Size Worth USD 3.03 Trillion by 2034
07 Oct 2025 06:27 GMT
Ottawa, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The global pharmaceutical market size is expected to be worth over USD 3.03 trillion by 2034, increasing from USD 1.77 trillion in 2025. It is expected to grow at a CAGR of 6.15% between 2025 and 2034. The growing …
-
Approaching Refractive Lens Exchange
10 Oct 2025 21:39 GMT
At our practice, we take a truly comprehensive approach to refractive surgery—one that spans the entire visual lifecycle. That means we don’t just correct nearsightedness or farsightedness; we address the changing needs of the eye at every stage of life, …
-
Global Protein Drugs Market to Reach $655.7 Billion by 2029
10 Oct 2025 18:27 GMT
Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- As demand for targeted, biologic-based treatments continues to grow, protein drugs are transforming how pharmaceutical companies address chronic, genetic, and life-threatening diseases. From monoclonal antibodies ( …
-
Precision Medicine Market Size Booms at 16.35% CAGR, Expected to Reach USD 463.11 Billion by 2034
10 Oct 2025 15:00 GMT
Ottawa, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The global precision medicine market size was valued at USD 101.86 billion in 2024 and is predicted to hit around USD 463.11 billion by 2034, rising at a 16.35% CAGR, a study published by Towards Healthcare a …
-
Complex Injectable Market to Expand at a 11.3% CAGR by 2029, Reaching US $30.38 Billion
10 Oct 2025 00:15 GMT
The Business Research Company’s Complex Injectable Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, October 10, 2025 /EINPresswire.com/ -- Get 20% Off All Global Market …
About
© 1995-2025